GBT PILLAR Trademark

Trademark Overview

On Friday, September 6, 2019, a trademark application was filed for GBT PILLAR with the United States Patent and Trademark Office. The USPTO has given the GBT PILLAR trademark a serial number of 88607386. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 5, 2022. This trademark is owned by Global Blood Therapeutics, Inc.. The GBT PILLAR trademark is filed in the Advertising, Business and Retail Services and Insurance & Financial Services categories with the following description:

Prescription drug claims administration services, namely, healthcare insurance verification in the nature of insurance claim verification and payer reimbursement assessment and verification for prescription drugs; providing patients who have been prescribed a course of therapy that involves prescription pharmaceuticals with information on available insurance benefits regarding pharmaceuticals, medical coverage, reimbursement options and financial support for that therapy

Pharmacy referral services provided via a global computer network; specialized retail pharmacy referral services for patients with particular medical conditions; promoting public awareness of the interests of sickle cell disease patients
gbt pillar

General Information

Serial Number88607386
Word MarkGBT PILLAR
Filing DateFriday, September 6, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 5, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 8, 2021

Trademark Statements

Pseudo MarkGLOBAL BLOOD THERAPEUTICS PILLAR
Goods and ServicesPrescription drug claims administration services, namely, healthcare insurance verification in the nature of insurance claim verification and payer reimbursement assessment and verification for prescription drugs; providing patients who have been prescribed a course of therapy that involves prescription pharmaceuticals with information on available insurance benefits regarding pharmaceuticals, medical coverage, reimbursement options and financial support for that therapy
Goods and ServicesPharmacy referral services provided via a global computer network; specialized retail pharmacy referral services for patients with particular medical conditions; promoting public awareness of the interests of sickle cell disease patients

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, September 18, 2019
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, September 18, 2019
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlobal Blood Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameGlobal Blood Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, September 6, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 5, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 4, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, February 3, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 1, 2022SOU EXTENSION 1 GRANTED
Tuesday, February 1, 2022SOU EXTENSION 1 FILED
Tuesday, February 1, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, August 3, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 8, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 8, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 19, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 3, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 30, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 29, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 5, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 5, 2020NON-FINAL ACTION E-MAILED
Thursday, November 5, 2020NON-FINAL ACTION WRITTEN
Monday, November 2, 2020ASSIGNED TO LIE
Tuesday, September 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 2, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 2, 2020LETTER OF SUSPENSION E-MAILED
Monday, March 2, 2020SUSPENSION LETTER WRITTEN
Friday, February 7, 2020ASSIGNED TO EXAMINER
Thursday, January 30, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 29, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 17, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 17, 2019NON-FINAL ACTION E-MAILED
Tuesday, December 17, 2019NON-FINAL ACTION WRITTEN
Monday, December 9, 2019ASSIGNED TO EXAMINER
Wednesday, September 18, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 10, 2019NEW APPLICATION ENTERED

Related Keywords

pillar prescription patients verification services insurance reimbursement therapy referral pharmaceuticals pharmacy